Italia - italiano - myHealthbox

ca.di.group srl - maltodestrina da tapioca; agente di carica: maltodestrine;fibre solubili: fruttooligosaccaridi (fos), inulina; vitamina c rivestita; ceppi probiotici microincapsulati: b. lactis bs01, l. plantarum lp09, l. rhamnosus lr06, s. thermophilus st15, l. acidophilus la02, b. infantis bi02, b. longum bl03, l. salivarius ls03,;vitamina e (di-alfa-tocoferil-acetato); edulcorante: rebaudioside a da stevia rebaudiana. - 5g - equilibratori flora batterica - utile nel riequilibrio della flora di tutto l'intestino conseguente a squilibri alimentari, terapie antibiotiche e disturbi funzionali. contribuisce a rafforzare il sistema immunitario.

Unione Europea - italiano - EMA (European Medicines Agency)

celltrion healthcare hungary kft. - bevacizumab - colorectal neoplasms; breast neoplasms; ovarian neoplasms; fallopian tube neoplasms; peritoneal neoplasms; carcinoma, non-small-cell lung; carcinoma, renal cell; uterine cervical neoplasms - agenti antineoplastici - vegzelma in combination with fluoropyrimidine based chemotherapy is indicated for treatment of adult patients with metastatic carcinoma of the colon or rectum. vegzelma in combination with paclitaxel is indicated for first line treatment of adult patients with metastatic breast cancer. per ulteriori informazioni sullo stato del recettore del fattore di crescita epidermico umano 2 (her2), fare riferimento alla sezione 5. vegzelma in combination with capecitabine is indicated for first line treatment of adult patients with metastatic breast cancer in whom treatment with other chemotherapy options including taxanes or anthracyclines is not considered appropriate. patients who have received taxane and anthracycline containing regimens in the adjuvant setting within the last 12 months should be excluded from treatment with vegzelma in combination with capecitabine. per ulteriori informazioni sullo stato her2, fare riferimento alla sezione 5. vegzelma, in addition to platinum based chemotherapy, is indicated for first line treatment of adult patients with unresectable advanced, metastatic or recurrent non small cell lung cancer (nsclc) other than predominantly squamous cell histology. vegzelma, in combination with erlotinib, is indicated for first line treatment of adult patients with unresectable advanced, metastatic or recurrent nsclc with epidermal growth factor receptor (egfr) activating mutations (see section 5. vegzelma, in combination with interferon alfa 2a is indicated for first line treatment of adult patients with advanced and/or metastatic renal cell cancer. vegzelma, in combination with carboplatin and paclitaxel is indicated for the front line treatment of adult patients with advanced (international federation of gynecology and obstetrics (figo) stages iii b, iii c and iv) epithelial ovarian, fallopian tube, or primary peritoneal cancer (see section 5. vegzelma, in combination with carboplatin and gemcitabine or in combination with carboplatin and paclitaxel, is indicated for treatment of adult patients with first recurrence of platinum sensitive epithelial ovarian, fallopian tube or primary peritoneal cancer who have not received prior therapy with bevacizumab or other vascular endothelial growth factor (vegf) inhibitors or vegf receptor–targeted agents. vegzelma in combination with paclitaxel, topotecan, or pegylated liposomal doxorubicin is indicated for the treatment of adult patients with platinum resistant recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who received no more than two prior chemotherapy regimens and who have not received prior therapy with bevacizumab or other vegf inhibitors or vegf receptor–targeted agents (see section 5. vegzelma, in combination with paclitaxel and cisplatin or, alternatively, paclitaxel and topotecan in patients who cannot receive platinum therapy, is indicated for the treatment of adult patients with persistent, recurrent, or metastatic carcinoma of the cervix (see section 5.

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

b. braun medical ag - iodum, alcol isopropylicus - soluzione - iodum 0.9 mg ut povidonum iodinatum, alcohol isopropylicus 455 mg, natrii dihydrogenophosphas dihydricus, kalii iodidum, aqua purificata q.s. ad solutionem pro 1 ml. - pelle e wunddesinfiziens - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

b. braun medical ag - iodum, alcol isopropylicus - soluzione - iodum 0.9 mg ut povidonum iodinatum, alcohol isopropylicus 455 mg, natrii dihydrogenophosphas dihydricus, kalii iodidum, e 110, e 124, e 151, aqua purificata q.s. ad solutionem pro 1 ml. - pelle e wunddesinfiziens - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

ge healthcare ag - iodum, natrium - soluzione iniettabile - iohexolum 755 mg corresp. iodum 350 mg, trometamolum, natrii calcii edetas corresp. natrium 12 µg, acidum hydrochloridum ad ph, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - röntgenkontrastmittel - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

b. braun medical ag - iodum - lösung - iodum 7.8 mg ut povidonum iodinatum 78 mg, excipiens annuncio solutionem pro 1 ml. - haut - und händedesinfektion - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

b. braun medical ag - iodum - lösung mit schaumapplikator - iodum 7,7 mg ut povidonum iodinatum, excipiens annuncio solutionem pro 1 ml. - desinfiziens für haut, schleimhaut und wunden - synthetika

Italia - italiano - Ministero della Salute

vetcare oy - detomidina cloridrato - detomidina cloridrato - 10 mg/ml - detomidine

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

bayer (schweiz) ag - retinoli palmitas, thiamini hydrochloridum, riboflavinum, nicotinamidum, acidum pantothenicum, pyridoxini hydrochloridum, biotinum, acidum folicum, cyanocobalaminum, acidum ascorbicum, cholecalciferolum, rrr-alpha-tocopherolum, ginseng extractum siccum, calcium, magnesium, ferrum, zincum, cuprum, iodum, manganum, selenium - compresse rivestite con film - retinoli palmitas 1333 u.i., thiamini hydrochloridum 2.1 mg ut thiamini nitras 2.04 mg, riboflavinum 2.4 mg, nicotinamidum 18 mg, acidum pantothenicum 6 mg ut calcii pantothenas 6.52 mg, pyridoxini hydrochloridum 3 mg, biotinum 75 µg, acidum folicum 0.3 mg, cyanocobalaminum 1.5 µg, acidum ascorbicum 90 mg ut calcii ascorbas 108.9 mg, cholecalciferolum 200 u.i., rrr-alpha-tocopherolum 15 mg ut int-rac-alpha-tocopherylis acetas 22.38 mg, ginseng extractum siccum 50 mg, calcium 160 mg ut calcii carbonas 369.96 mg et calcii ascorbas et calcii pantothenas, magnesium 120 mg ut magnesii oxidum ponderosum 198.32 mg et magnesii stearas 10 mg, ferrum 5.6 mg ut ferrosi fumaras 17.04 mg, zincum 6 mg ut zinci citras trihydricus 19.22 mg, cuprum 1 mg ut cupri sulfas 2.51 mg, iodum 60 µg ut kalii iodidum 80.5 µg, manganum 1.4 mg ut mangani sulfas monohydricus 4.31 mg, selenium 28 µg ut natrii selenis 60 µg, povidonum k 30, gelatina, carmellosum natricum conexum, mannitolum, macrogolum 6000, lactosum 220.6 mg, hypromellosum, hydroxypropylcellulosum, talcum, titanii dioxidum, e 141, saccharum 1.95 mg, maydis amylum, natrii ascorbas, triglycerida media, silica colloidalis anhydrica, amylum modificatum, e 1450, glucosum liquidum dispersione desiccatum max. 10.95 mg pro compresso obducto corresp. natrium 0.94 mg. - la vitamina e mineralstoffpräparat - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

bayer (schweiz) ag - retinoli palmitas, thiamini hydrochloridum, riboflavinum, nicotinamidum, acidum pantothenicum, pyridoxini hydrochloridum, biotinum, acidum folicum, cyanocobalaminum, acidum ascorbicum, cholecalciferolum, rrr-alpha-tocopherolum, ginseng extractum siccum, calcium, magnesium, cuprum, iodum, ferrum, manganum, selenium, zincum - compresse effervescenti - retinoli palmitas 1333 u.i., thiamini hydrochloridum 2.1 mg ut monophosphothiamini chloridum, riboflavinum 2.4 mg ut riboflavini natrii phosphas, nicotinamidum 18 mg, acidum pantothenicum 6 mg ut calcii pantothenas, pyridoxini hydrochloridum 3 mg, biotinum 75 µg, acidum folicum 300 µg, cyanocobalaminum 1.5 µg, acidum ascorbicum 90 mg, cholecalciferolum 200 u.i., rrr-alpha-tocopherolum 15 mg ut int-rac-alpha-tocopherylis acetas, ginseng extractum siccum 50 mg, calcium 160 mg ut calcii carbonas et calcii glycerophosphas et calcii pantothenas, magnesium 120 mg ut magnesii hydrogenophosphas trihydricus et magnesii oxidum ponderosum, cuprum 1 mg ut cupri(ii) d-gluconas, iodum 60 µg ut kalii iodidum, ferrum 5.6 mg ut ferrosi lactas dihydricus, manganum 1.4 mg ut mangani sulfas monohydricus, selenium 28 µg ut natrii selenis, zincum 6 mg ut zinci citras trihydricus, acidum citricum, natrii hydrogenocarbonas, natrii carbonas, maltitolum 168.56 mg, sorbitolum 353.92 mg, povidonum k 30, polysorbatum 60, crospovidonum, mannitolum, polysorbatum 80, simeticonum, sacchari monopalmitas, e 162, e 160(a), cocois oleum, maltodextrinum, acaciae gummi, saccharum 7.27-9.02 mg, e 301, silica colloidalis anhydrica, e 307, natrii chloridum, aspartamum 40 mg, acesulfamum kalicum, aromatica (orange), aromatica (passionsfrucht), natrii citras dihydricus, gelatina, maydis amylum, sojae oleum partim hydrogenatum 0.18 mg, amylum modificatum, pro compresso corresp. natrium 227 mg. - la vitamina e mineralstoffpräparat - synthetika